石四药集团取得国家药监局有关别嘌醇片的药品生产注册批件

Core Viewpoint - The company has obtained the drug production registration approval for Allopurinol Tablets (0.1g) from the National Medical Products Administration of China, which is classified as a Class 3 chemical drug and is considered to have passed the consistency evaluation [1] Group 1 - Allopurinol Tablets are primarily used for the treatment of patients with primary or secondary gout, leukemia, lymphoma, and malignant tumors, as well as for patients with recurrent calcium oxalate stones [1]